Investors
Stock
Information
EURONEXT PARIS / B COMPARTMENT
FR0004065605 / MEDCL
28,718,045
KEPLER CHEUVREUX
BRYAN GARNIER & CO
KEPLER CHEUVREUX
ODDO-BHF
TP ICAP
PORTZAMPARC-BNP PARIBAS GROUP
Investors
Events &
Presentations
PREVIOUS EVENTS
September 12, 2023
2023 General Meeting (in French)
Replay
September 08, 2022
General Meeting (French)
Replay
September 05, 2022
Videoconference • General meeting preparation (French)
Replay
April 23, 2020
Video Conference • Adapt and overcome to the Covid-19 crisis
Replay
See all
Regulated informations
July 23 Half-year Liquidity contract statement
Jan. 2023 Half-year Liquidity contract statement
July 2022 Half-year Liquidity contract statement
See allJan. 2022 Half-year liquidity contract statement
July 2021 Half-year liquidity contract statement
Jan. 2021 Half-year liquidity contract statement
July 2020 Half-year liquidity contract statement
Jan. 2020 Half-year liquidity contract statement
Jan. 2020 Half-Year liquidity contract report (French)
Shares & Voting rights
See allAnnual reports
See allInvestors
General
Meeting
September 2023
See all
See all
See all
See all
See all
See all
Investors
Contacts
MedinCell
Head of Communication / IR
David Heuzé
david.heuze@medincell.com
+33 (0)6 83 25 21 86
MedinCell
Senior Communications Officer
Nicolas Gourgues
nicolas.gourgues@medincell.com
Investor Relations
NewCap
Louis-Victor Delouvrier & Alban Dufumier
medincell@newcap.eu
+33 (0)1 44 71 94 94
Media
NewCap
Nicolas Merigeau
medincell@newcap.eu
+33 (0)1 44 71 94 94